BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34094970)

  • 1. Sub-Classification of Cirrhosis Affects Surgical Outcomes for Early Hepatocellular Carcinoma Independent of Portal Hypertension.
    Zhang EL; Li J; Li J; Wang WQ; Gu J; Huang ZY
    Front Oncol; 2021; 11():671313. PubMed ID: 34094970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the severity of liver cirrhosis through clinical parameters.
    Zhang EL; Zhang ZY; Wang SP; Xiao ZY; Gu J; Xiong M; Chen XP; Huang ZY
    J Surg Res; 2016 Aug; 204(2):274-281. PubMed ID: 27565061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic severity of liver cirrhosis: A key factor affecting surgical outcomes of hepatocellular carcinoma in patients with portal hypertension.
    Dong KS; Liang BY; Zhang ZY; Zhang EL; Yang G; Xia SL; Chen XP; Huang ZY
    Asian J Surg; 2019 Dec; 42(12):981-989. PubMed ID: 30782497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy.
    Kim BK; Oh HJ; Park JY; Kim DY; Ahn SH; Han KH; Park Y; Yoo EJ; Park YN; Kim SU
    Liver Int; 2013 Feb; 33(2):180-9. PubMed ID: 23295050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinoma.
    Zhang EL; Liang BY; Chen XP; Huang ZY
    World J Surg Oncol; 2015 Apr; 13():148. PubMed ID: 25879526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy.
    Liang BY; Gu J; Xiong M; Zhang EL; Zhang ZY; Lau WY; Wang SF; Guan Y; Chen XP; Huang ZY
    J Hepatocell Carcinoma; 2022; 9():633-647. PubMed ID: 35909916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function.
    Gu J; Zhang E; Liang B; Zhang Z; Chen X; Huang Z
    World J Surg Oncol; 2020 Apr; 18(1):79. PubMed ID: 32326968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic liver resections for hepatocellular carcinoma. Can we extend the surgical indication in cirrhotic patients?
    Cipriani F; Fantini C; Ratti F; Lauro R; Tranchart H; Halls M; Scuderi V; Barkhatov L; Edwin B; Troisi RI; Dagher I; Reggiani P; Belli G; Aldrighetti L; Abu Hilal M
    Surg Endosc; 2018 Feb; 32(2):617-626. PubMed ID: 28717870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma.
    Kim SU; Jung KS; Lee S; Park JY; Kim DY; Ahn SH; Choi GH; Kim KS; Choi JS; Han KH; Park YN
    Liver Int; 2014 Aug; 34(7):1008-17. PubMed ID: 24483989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: A multicenter analysis of 1,066 patients.
    Li ZL; Yu JJ; Guo JW; Sui CJ; Dai BH; Zhang WG; Chen TH; Li C; Gu WM; Zhou YH; Wang H; Zhang YM; Mao XH; Pawlik TM; Wang MD; Liang L; Wu H; Lau WY; Wu MC; Shen F; Yang T
    Eur J Surg Oncol; 2019 May; 45(5):800-807. PubMed ID: 30594407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.
    Citterio D; Facciorusso A; Sposito C; Rota R; Bhoori S; Mazzaferro V
    JAMA Surg; 2016 Sep; 151(9):846-53. PubMed ID: 27248425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
    Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
    J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term and long-term outcomes of surgical treatment for HCC within Milan criteria with cirrhotic portal hypertension.
    Chuan W; Li C; Wen TF; Yan LN; Li B; Liang GL; Li KW
    Hepatogastroenterology; 2014; 61(136):2185-90. PubMed ID: 25699347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.
    Kim MY; Cho MY; Baik SK; Park HJ; Jeon HK; Im CK; Won CS; Kim JW; Kim HS; Kwon SO; Eom MS; Cha SH; Kim YJ; Chang SJ; Lee SS
    J Hepatol; 2011 Nov; 55(5):1004-9. PubMed ID: 21354227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Severity of Liver Cirrhosis on Surgical Outcomes of Hepatocellular Carcinoma After Liver Resection and Microwave Coagulation.
    Li J; Tao HS; Li J; Wang WQ; Sheng WW; Huang ZY; Zhang EL
    Front Oncol; 2021; 11():745615. PubMed ID: 34692526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.